1. F. Parente, C. Cucino, S. Bollani, V. Imbesi, G. Maconi, S. Bonetto, L. Vago, G. Bianchi Porro: Focal gastric inflammatory infiltrates in inflammatory bowel diseases: prevalence, immunohistochemical characteristics, and diagnostic role. Amer. J. Gastroenterol. : 95, 705-711, 2000 I.F. 4.716
2. S. Ardizzone, S. Bollani, P. Bettica, M. Bevilacqua, P. Molteni, G. Bianchi Porro: Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis. J. Intern. Med.: 247, 63-70, 2000 I.F. 3.590
3. F. Parente, V. Imbesi, C. Cucino, G. Maconi, U. Russo, P.G. Duca, G. Bianchi Porro: Helicobacter pylori CagA seropositivity does not influence inflammatory parameters, lipid concentrations and haemostatic factors in healthy individuals. J. Intern. Med.: 247, 213-217, 2000 I.F. 3.590
4. G. Maconi, G.M. Sampietro, M. Cristaldi, PG. Danelli, A. Russo, G. Bianchi Porro, A.M. Taschieri: Preoperative characteristics and postoperative behavior of bowel wall on risk of recurrence after conservative surgery in Crohn’s disease. A prospective study. Ann. Surg.: 233, 345-352, 2001 I.F. 5.907
5. G. Maconi, F. Parente, A. Russo, L. Vago, V. Imbesi, G. Bianchi Porro: Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy ? Amer. J. Gastroenterol.: 96, 359-366, 2001 I.F. 4.716
6. M. Lazzaroni, G. Bianchi Porro: Nonsteroidal anti-inflammatory drug gastropathy and Helicobacter pylori: the search for an improbable consensus. Amer. J. Med.: 110, suppl. 1A, 50S-54S, 2001 I.F. 4.179
7. M. Lazzaroni, M. Petrillo, R. Tornaghi, E. Massironi, M. Sainaghi, N. Principi, G. Bianchi Porro: Upper GI bleeding in healthy full-term infants: a case-control study. Amer. J. Gastroenterol.: 97, 89-94, 2002 I.F. 4.716
8. F. Parente, G. Maconi, S. Bollani, A. Anderloni, G. Sampietro, M. Cristaldi, N. Franceschelli, R. Bianco, A.M. Taschieri, G. Bianchi Porro: Bowel ultrasound in assessment of Crohn’s disease and detection of related small bowel strictures: a prospective comparative study versus x ray and intraoperative findings. Gut: 50, 490-495, 2002 I.F. 6.601
9. G. Maconi, G.M. Sampietro, A. Russo, S. Bollani, M. Cristaldi, F. Parente, F. Dottorini, G. Bianchi Porro: The vascularity of internal fistulae in Crohn’s disease: an in vivo power Doppler ultrasonography assessment. Gut: 50, 496-500, 2002 I.F. 6.601
10. M.C.J.M. Sturkenboom, F. Romano, G. Simon, M.L. Correa-Leite, M. Villa, A. Nicolosi, G. Borgnolo, G. Bianchi Porro, S. Mannino: The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum-Arthr. Care Re.: 47,132-140, 2002 I.F. 7.414
11. M. Lazzaroni, G. Bianchi Porro: Preparation, premedication and surveillance. Endoscopy: 35, 103-111, 2003 I.F. 4.034
12. G. Maconi, G.M. Sampietro, F. Parente, G. Pompili, A. Russo, M. Cristaldi, G. Arborio, S. Ardizzone, G. Matacena, A.M. Taschieri, G. Bianchi Porro: Contrast radiology, computed tomography and ultrasonography in detecting internal fistulas and intra-abdominal abscesses in Crohn’s disease: a prospective comparative study. Amer. J. Gastroenterol. : 98, 1545-1555, 2003 I.F. 4.716
13. F. Pace, G. Bianchi Porro: Gastroesophageal reflux disease: a typical spectrum disease (a new conceptual framework is not needed). Amer. J. Gastroenterol.: 99, 946-949, 2004 I.F. 4.716
14. F. Parente, A. Anderloni, S. Greco, P. Zerbi, G. Bianchi Porro: Image of the month: Ileocecal Burkitt’s lymphoma. Gastroenterology: 127, 8,368, 2004 I.F. 13.092
15. S. Ardizzone, G. Maconi, G.M. Sampietro, A. Russo, E. Radice, E. Colombo, V. Imbesi, M. Molteni, P.G. Danelli, A.M. Taschieri, G. Bianchi Porro: Azathioprine and mesalamine for prevention of relapse after conservative surgery for Crohn’s disease. Gastroenterology: 127, 730-740, 2004 I.F. 13.092
16. M. Lazzaroni, G. Bianchi Porro: Gastrointestinal side effects of traditional non-steroidal anti-inflammatory drugs and new formulations. Aliment. Pharmacol. Ther.: 20, (Suppl. 2), 48-58, 2004 I.F. 3.981
17. F. Parente, S. Greco, M. Molteni, A. Anderloni, G.M. Sampietro, P. Danelli, R. Bianco, S. Gallus, G. Bianchi Porro: Oral contrast enhanced bowel ultrasonography in the assessment of small intestine Crohn’s disease. A prospective comparison with conventional ultrasound, X-ray studies, and ileo-colonoscopy. Gut: 53, 1652-1657, 2004 I.F. 6.601
18. M. Lazzaroni, G. Bianchi Porro: Preparation, premedication, and surveillance. Endoscopy: 37, 101-109, 2005 I.F. 4.034
19. M. Bevilacqua, L.J. Dominguez, V. Righini, V. Valdes, R. Toscano, O. Sangaletti, T. Vago, G. Baldi, M. Barrella, G. Bianchi Porro: Increased gastrin and calcitonin secretion after oral calcium or peptones administration in patients with hypercalciuria: a clue to an alteration in calcium-sensing receptor activity. J. Clin Endocrinol. Metab.: 90, 1489-1494, 2005 I.F. 5.778
20. C. Hawkey, N.J. Talley, N.D. Yeomans, R. Jones, J.J.Y. Sung, G. Langstrom, J. Naesdal, J.M. Scheiman, G. Bianchi Porro et al. on behalf of the NASA1 SPACE1 Study Group: Improvements with esomeprazole in patients with upper gastrointestinal symptoms taking non-steroidal antiinflammatory drugs, including selective COX-2 inhibitors. Amer J. Gastroenterol.: 100, 1028-1036, 2005 I.F. 4.716
21. S. Ardizzone, G. Bianchi Porro: Biological therapy for inflammatory
bowel disease. Drugs: 65, 2253-2286, 2005 I.F. 4.412
22. S. Bargiggia, D. Thornburn, A. Anderloni, S. Ardizzone, R. Giorgi,G. Bianchi Porro, F. Parente: Is interferon alpha therapy safe and effectivefor patients with chronic hepatitis C and inflammatory bowel disease? Acase-control study. Aliment. Pharmacol. Ther.: 22, 209-215, 2005 I.F. 3.981
23. S. Ardizzone, G. Maconi, A. Russo, V. Imbesi, E. Colombo, G. BianchiPorro: Randomised, controlled trial of azathioprine and 5-aminosalicylicacid for treatment of steroid-dependent ulcerative colitis. Gut: 55, 47-53, 2006 I.F 6.601
24. R. Furlan, S. Ardizzone, L. Palazzolo, A. Rimoldi, F. Perego, F. Barbic, M. Bevilacqua, L. Vago, G. Bianchi Porro, A. Malliani: Sympathetic overactivity in active ulcerative colitis: effects of clonidine. Am. J. Physiol.-Regul. Integr. Comp. Physiol.: 290, R224-R232, 2006 I.F. 3.405
